aidenb, I wanted to follow-up and provide the stat
Post# of 148184
(Total Views: 332)
Posted On: 11/14/2019 9:03:03 AM
aidenb, I wanted to follow-up and provide the statement and link to the PR I was referencing, but didn't have time to look it up yesterday when posting from my phone.
It's from the May 8th PR: CytoDyn Provides Updated Pre-Clinical Data Showing Leronlimab (PRO 140) Continues to Suppress Breast Cancer Metastatic Burden >98% Compared with Untreated Animals
https://www.cytodyn.com/newsroom/press-releas...ta-showing
Quote:
With recently granted Fast Track Designation for mTNBC, Section 561A(f)(2) of the FD&C Act, now requires leronlimab to be available within 15 days under expanded access policy for patients with serious or life-threatening illnesses
It's from the May 8th PR: CytoDyn Provides Updated Pre-Clinical Data Showing Leronlimab (PRO 140) Continues to Suppress Breast Cancer Metastatic Burden >98% Compared with Untreated Animals
https://www.cytodyn.com/newsroom/press-releas...ta-showing
(0)
(0)CytoDyn Inc (CYDY) Stock Research Links
Please do your own due diligence. All my posts and comments are not to be considered investment advice.
Scroll down for more posts ▼